Christopher H. Atkinson

917 total citations
18 papers, 719 citations indexed

About

Christopher H. Atkinson is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher H. Atkinson has authored 18 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher H. Atkinson's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Christopher H. Atkinson is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Christopher H. Atkinson collaborates with scholars based in New Zealand, Australia and Canada. Christopher H. Atkinson's co-authors include Peter J. Davidson, Andrew Troy, Derek N.J. Hart, Kelly L. Summers, B M Colls, P J Dady, Bridget A. Robinson, Bernard M. Fitzharris, Ian Kennedy and V.J. Harvey and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Christopher H. Atkinson

18 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher H. Atkinson New Zealand	12	361	360	134	95	87	18	719
Felix Klug Germany	8	650 1.8×	616 1.7×	181 1.4×	192 2.0×	76 0.9×	8	1.0k
Mitsunori Higuchi Japan	14	275 0.8×	170 0.5×	250 1.9×	126 1.3×	67 0.8×	77	654
Alexander Filatenkov United States	10	339 0.9×	303 0.8×	118 0.9×	93 1.0×	38 0.4×	19	647
Anu Autio Finland	15	143 0.4×	179 0.5×	88 0.7×	189 2.0×	45 0.5×	26	631
Harald Fricke Germany	15	127 0.4×	201 0.6×	64 0.5×	218 2.3×	56 0.6×	31	753
Daniel Yoder United States	4	293 0.8×	591 1.6×	66 0.5×	104 1.1×	26 0.3×	6	823
Roni Rayes Canada	14	284 0.8×	691 1.9×	98 0.7×	205 2.2×	100 1.1×	39	1.0k
A Scholz Germany	9	148 0.4×	72 0.2×	64 0.5×	138 1.5×	58 0.7×	16	445
Patricia Baxter United States	17	266 0.7×	57 0.2×	149 1.1×	295 3.1×	99 1.1×	50	927
Damu Yang Japan	9	360 1.0×	527 1.5×	200 1.5×	307 3.2×	59 0.7×	12	868

Countries citing papers authored by Christopher H. Atkinson

Since Specialization

Citations

This map shows the geographic impact of Christopher H. Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Atkinson more than expected).

Fields of papers citing papers by Christopher H. Atkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Atkinson. The network helps show where Christopher H. Atkinson may publish in the future.

Co-authorship network of co-authors of Christopher H. Atkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Atkinson. A scholar is included among the top collaborators of Christopher H. Atkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Atkinson. Christopher H. Atkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Delahunt, Brett, David S. Lamb, John R. Srigley, et al.. (2010). Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point. Pathology. 42(4). 339–343. 36 indexed citations

2.

Bartoň, Michael, Martin H.N. Tattersall, Phyllis Butow, et al.. (2003). Cancer knowledge and skills of interns in Australia and New Zealand in 2001: comparison with 1990, and between course types. The Medical Journal of Australia. 178(6). 285–289. 38 indexed citations

3.

Atkinson, Christopher H., David Joseph, Stephen P. Ackland, et al.. (1999). Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australasian Radiology. 43(2). 220–226. 13 indexed citations

4.

Troy, Andrew, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1999). CD1A DENDRITIC CELLS PREDOMINATE IN TRANSITIONAL CELL CARCINOMA OF BLADDER AND KIDNEY BUT ARE MINIMALLY ACTIVATED. The Journal of Urology. 1962–1967. 2 indexed citations

5.

Troy, Andrew, Kelly L. Summers, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1999). Minimal Recruitment and Activation of Dendritic Cells Within Renal Cell Carcinoma. The Journal of Urology. 4(3). 1737–1738. 166 indexed citations

6.

Troy, Andrew, Kelly L. Summers, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1999). Minimal Recruitment and Activation of Dendritic Cells Within Renal Cell Carcinoma. The Journal of Urology. 161(5). 1737–1738. 77 indexed citations

7.

Troy, Andrew, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1999). CD1A DENDRITIC CELLS PREDOMINATE IN TRANSITIONAL CELL CARCINOMA OF BLADDER AND KIDNEY BUT ARE MINIMALLY ACTIVATED. The Journal of Urology. 161(6). 1962–1967. 40 indexed citations

8.

Troy, Andrew, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1998). The contribution of dendritic cells to immune responses against urological cancers. Urologic Oncology Seminars and Original Investigations. 4(1). 17–23. 4 indexed citations

9.

Troy, Andrew, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1998). PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER. The Journal of Urology. 160(1). 214–219. 115 indexed citations

10.

Troy, Andrew, Peter J. Davidson, Christopher H. Atkinson, & Derek N.J. Hart. (1998). PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER. The Journal of Urology. 214–219. 7 indexed citations

11.

Probert, John C. & Christopher H. Atkinson. (1996). New Zealand: One small country's history of radiation oncology. International Journal of Radiation Oncology*Biology*Physics. 36(2). 481–486. 1 indexed citations

12.

Hill, Geoffrey R., et al.. (1996). Acquired heparin-like anticoagulants: a second case in metastatic breast carcinoma and literature review. Clinical & Laboratory Haematology. 18(4). 291–295. 7 indexed citations

13.

Denham, James W., C.S. Hamilton, David Christie, et al.. (1995). Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer—toxicity and dose modification: A transtasman radiation oncology group multi-institution study. International Journal of Radiation Oncology*Biology*Physics. 31(2). 305–313. 26 indexed citations

14.

Atkinson, Christopher H., C.S. Hamilton, & Christopher Wynne. (1994). Radiotherapy planning for lung cancer: Can we do better?. Australasian Radiology. 38(4). 303–304. 1 indexed citations

15.

Robinson, Bridget A., et al.. (1994). Second malignant neoplasms in patients with Hodgkin's disease. Australian and New Zealand Journal of Medicine. 24(4). 368–373. 11 indexed citations

16.

Hamilton, C.S., James W. Denham, David Joseph, et al.. (1992). Treatment and planning decisions in non-small cell carcinoma of the lung: An Australasian patterns of practice study. Clinical Oncology. 4(3). 141–147. 29 indexed citations

17.

Pérez, David, V.J. Harvey, Bridget A. Robinson, et al.. (1991). A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer.. Journal of Clinical Oncology. 9(12). 2148–2152. 93 indexed citations

18.

Kennedy, Ian, Bernard M. Fitzharris, B M Colls, & Christopher H. Atkinson. (1990). Carboplatin is ototoxic. Cancer Chemotherapy and Pharmacology. 26(3). 232–234. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact